SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
AstraZeneca
AstraZeneca
Politics
AstraZeneca begins European exit—will invest $50 billion in the U.S. amid tariff threats
By
AFP
July 22, 2025
Politics
U.K. business leaders are ‘struggling to see what’s business-friendly’ about Labour
By
Jamie Nimmo
,
Irina Anghel
,
Jennifer Creery
and
Bloomberg
July 7, 2025
Economy
New London IPOs hit 28-year low amid AstraZeneca exit concerns
By
Pablo Mayo Cerqueiro
,
Joe Easton
,
Neil Campling
and
Bloomberg
July 3, 2025
Finance
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
By
AFP
April 29, 2025
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By
Ashleigh Furlong
and
Bloomberg
March 17, 2025
Health
AstraZeneca sees profits surge despite Chinese import tax allegations
By
AFP
February 6, 2025
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By
Lindsey Leake
January 22, 2025
Success
Ryanair’s Michael O’Leary, who is up for a $108 million bonus, doesn’t see high CEO pay as a problem: ‘Footballers are getting half a million a week’
By
Prarthana Prakash
January 10, 2025
Health
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
By
Lindsey Leake
December 20, 2024
Retail
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
By
AFP
November 12, 2024
Leadership
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By
AFP
November 7, 2024
Finance
AstraZeneca’s drive for China dominance in focus as chief probed
By
Amber Tong
and
Bloomberg
October 31, 2024
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By
Ashleigh Furlong
and
Bloomberg
May 21, 2024
Health
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
By
The Associated Press
May 9, 2024
Success
Ryanair’s Michael O’Leary, who is up for a $108 million bonus, doesn’t see high CEO pay as a problem: ‘Footballers are getting half a million a week’
By
Prarthana Prakash
April 29, 2024
Most Popular
Retail
Walmart and Target are allegedly forcing employees to remove tags on apparel to make it easier to jack up prices based...
By
Erin Cabrey
and
Retail Brew
Economy
Ray Dalio says 'most people are silent' because they're afraid to talk about what's really happening with the U.S....
By
Dave Smith
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore